Aphexda 62 mg lyophilized powder for injection Images
Generic Name: motixafortide
This medication has been identified as Aphexda 62 mg lyophilized powder for injection. It is supplied by BioLineRx Ltd.
Aphexda is used in the treatment of Hematopoietic Stem Cell Mobilization; Multiple Myeloma and belongs to the drug class hematopoietic stem cell mobilizer. Aphexda 62 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Aphexda
- Generic Name
- motixafortide
- Strength
- 62 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Hematopoietic stem cell mobilizer
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BioLineRx Ltd.
- National Drug Code (NDC)
- 82737-0073
More about Aphexda (motixafortide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hematopoietic stem cell mobilizer
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
